Opportunity Finder — Daily Report
Top 10 — quality × doubt
| # | Name | Sector | Qual %ile | Doubt | Recommended next step |
|---|---|---|---|---|---|
| 1 | ADBE Adobe Inc. | Technology | 97.4% | 1.00 | HOLD OFF — CONFIRM THE TURN |
| NEWS CONSTRUCTIVE Signals: cheap vs history · off highs · below trend · near low · turning up | |||||
| 2 | TTD The Trade Desk, Inc. | Communication Services | 91.4% | 1.00 | BUY CANDIDATE — WORTH A CLOSE LOOK |
| DEBATED Signals: cheap vs history · off highs · below trend · near low | |||||
| 3 | IT Gartner, Inc. | Industrials | 84.4% | 1.00 | BUY CANDIDATE — WORTH A CLOSE LOOK |
| DOUBT = SENTIMENT Signals: cheap vs history · off highs · below trend · near low | |||||
| 4 | ADSK Autodesk, Inc. | Technology | 87.4% | 0.91 | BUY CANDIDATE — WORTH A CLOSE LOOK |
| DOUBT = SENTIMENT Signals: cheap vs history · off highs · below trend · near low | |||||
| 5 | IDXX IDEXX Laboratories, Inc. | Healthcare | 98.2% | 0.79 | HOLD OFF — CONFIRM THE TURN |
| DOUBT = SENTIMENT Signals: cheap vs history · off highs · below trend · near low · turning up | |||||
| 6 | RMD ResMed Inc. | Healthcare | 97.2% | 0.79 | BUY CANDIDATE — WORTH A CLOSE LOOK |
| DOUBT = SENTIMENT Signals: cheap vs history · off highs · below trend · near low | |||||
| 7 | ROL Rollins, Inc. | Consumer Cyclical | 88.0% | 0.86 | BUY CANDIDATE — WORTH A CLOSE LOOK |
| DOUBT = SENTIMENT Signals: cheap vs history · off highs · below trend · near low | |||||
| 8 | ZTS Zoetis Inc. | Healthcare | 92.8% | 1.00 | RECONSIDER — DOUBT MAY BE EARNED |
| DOUBT EARNED Signals: cheap vs history · off highs · below trend · near low | |||||
| 9 | INTU Intuit Inc. | Technology | 78.8% | 1.00 | RESEARCH THE CAUSE FIRST |
| DEBATED Signals: cheap vs history · off highs · below trend · near low | |||||
| 10 | ISRG Intuitive Surgical, Inc. | Healthcare | 91.2% | 0.80 | BUY CANDIDATE — WORTH A CLOSE LOOK |
| DOUBT = SENTIMENT Signals: cheap vs history · off highs · below trend · near low | |||||
Business quality (x) vs cumulative doubt (y). Oxblood = the doubted-quality quadrant — evidence to investigate, not a buy list.